Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AT1 receptor antagonists.

I Verheijen1, P M L Vanderheyden, J P De Backer

  • 1Department of Molecular and Biochemical Pharmacology, Free University of Brussels (VUB), 2 Pleinlaan, 1050 Brussels, Belgium. iverheij@minf.vub.ac.be

Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|August 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of drug distribution and drug-target binding on target occupancy: The rate-limiting step approximation.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2017
Same author

Medicinal plants in Suriname: screening of plant extracts for receptorbinding activity.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2012
Same author

Screening of medicinal plants from Suriname for 5-HT(1A) ligands: Bioactive isoquinoline alkaloids from the fruit of Annona muricata.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2012
Same author

Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approach.

British journal of pharmacology·2010
Same author

Conus venom interaction with ?(2)-adrenergic receptors in calf retina membranes.

Neurochemistry international·2010
Same author

(+/-)Tetrahydroanisocycline and (+/-)tetrahydropalmatine binding to D1 and D2 dopaminergic receptors in human putamen.

Neurochemistry international·2010

Selective AT1 receptor antagonists are crucial for cardiovascular homeostasis. Some antagonists exhibit insurmountable effects due to tight binding, potentially explaining their long-lasting clinical impact in treating hypertension and heart failure.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Type 1 receptors (AT1) for angiotensin II are vital for cardiovascular homeostasis.
  • Selective, orally active non-peptide AT1 antagonists are developed for hypertension and heart failure.
  • Pre-clinical testing distinguishes between surmountable and insurmountable antagonists based on angiotensin II response curves.

Purpose of the Study:

  • Investigate the molecular mechanism of insurmountable AT1 receptor antagonism.
  • Determine the influence of methodological approaches on in vitro AT1 receptor antagonist binding properties.
  • Clarify the relationship between antagonist binding kinetics and clinical effects.

Main Methods:

  • In vitro studies using Chinese Hamster Ovary cells expressing human AT1 receptors.

Related Experiment Videos

  • Analysis of angiotensin II concentration-response curves in rabbit aorta strips.
  • Investigation of biphenyltetrazole-countering AT1 receptor antagonist binding properties.

    • Main Results:

    • All biphenyltetrazole-countering AT1 receptor antagonists competitively inhibit angiotensin II.
    • Insurmountable antagonism is linked to the formation of a long-lasting/tight binding antagonist-receptor complex.
    • Methodological approaches can influence observed in vitro receptor binding properties.

    Conclusions:

    • The tight binding of certain AT1 antagonists to the receptor complex may underlie their prolonged clinical efficacy.
    • Understanding binding mechanisms is crucial for developing effective cardiovascular therapies.
    • Standardized methodologies are important for accurate assessment of AT1 receptor antagonist properties.